[Quinolone use and resistance].
Oteo
Jesús
J
Campos
José
J
D000328:Adult; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001426:Bacterial Proteins / Q000235:genetics / Q000502:physiology; D002648:Child; D027081:DNA Gyrase / Q000235:genetics / Q000502:physiology; D027101:DNA Topoisomerase IV / Q000235:genetics / Q000502:physiology; D004351:Drug Resistance / Q000235:genetics; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D004363:Drug Utilization; D005060:Europe; D024841:Fluoroquinolones / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009154:Mutation; D015242:Ofloxacin / Q000494:pharmacology / Q000627:therapeutic use; D019779:Salmonella enterica / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D014481:United States
D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D024841:Fluoroquinolones; D015242:Ofloxacin; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase